Market Research Report
Chinese Orthopedic Biomaterials Market
|Published by||iData Research Inc.||Product code||274587|
|Published||Content info||110 Pages
Delivery time: 1-2 business days
|Chinese Orthopedic Biomaterials Market|
|Published: June 26, 2013||Content info: 110 Pages||
This publication has been discontinued on January 9, 2019.
The Chinese orthopedic biomaterials market is expected to approach $522.3 million by 2019. The bone graft substitute segment is expected to constitute the majority of the Chinese orthopedic biomaterials market.
The Chinese orthopedic biomaterials market comprises bone graft substitutes which is segmented into allografts, demineralized bone matrices (DBM) and synthetics, and hyaluronic acid (HA) viscosupplementation. The market has seen increased interest in domestic competitors and some domestic competitors are in the process of clinical trials for synthetic, DBM, and bone morphogenetic protein (BMP) products. Further growth in the overall market will be fuelled by the Chinese government improving healthcare coverage across the country, leading to an increase in the number of Chinese people with more disposable income. The previous drivers are magnified by the increasing population of elderly, and the increased acceptance of surgery as a solution.
This report pertains to a forecast period of 10 years (2009 - 2019) for China.
Award Trade Corporation (Kunming), Beijing Fito Medical, Beijing St. Jane Medical, Liweize Medical Devices, Shanghai Medcare, Shenzhen SMARL, and various domestic companies
This report analyzes and evaluates the current state of the market including existing and potential markets, product average selling prices, and unit volumes. The report also highlights the opportunities and potential hazards involved, and presents strategies for successfully navigating the market landscape. Furthermore, it seeks to identify the trends and technologies that will affect the future of each market segment and prepares an unbiased critical assessment of such market drivers and limiters based on our “ground up” approach, which includes primary and secondary research methods.